Aug 23 (Reuters) - AstraZeneca (AZN.L), opens new tab has warned it could relocate its vaccine manufacturing site from the UK to the United States as talks with the new Labour government over ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
Drugs giant AstraZeneca has warned it could relocate its vaccine manufacturing site from the UK to the US amid a deadlock with the new Labour government over plans to cut state aid, the Financial ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. AstraZeneca has warned it could relocate its vaccine manufacturing site on Merseyside to Philadelphia amid ...
Drugmaker AstraZeneca has teamed up with Indian digital ... more than 250,000 images generated at clinics in the Greater Manchester Cancer Alliance, to see if Qure.ai's qXR software can make ...
British pharma giant AstraZeneca plans to spend $135 million to expand the manufacturing operations footprint of its site in Södertälje, Sweden, by 50%. The project calls for a 2,700-square ...
AstraZeneca has shared an early look at the performance of its in-house antibody-drug conjugate (ADC) technology, publishing phase 1 data on candidates that could compete with molecules from ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The applause mentioned above was for AstraZeneca’s Phase 3 NIAGARA study in bladder cancer, which showed that giving patients the checkpoint inhibitor Imfinzi — both before and after surgery ...
LONDON, Sept 9 (Reuters) - Detailed results from one of AstraZeneca's (AZN.L), opens new tab key lung cancer trials released on Monday showed that its experimental precision drug did not ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback